Annual EBITDA
$1.72 B
-$99.00 M-5.44%
31 December 2023
Summary:
Quest Diagnostics Incorporated annual earnings before interest, taxes, depreciation & amortization is currently $1.72 billion, with the most recent change of -$99.00 million (-5.44%) on 31 December 2023. During the last 3 years, it has fallen by -$1.44 billion (-45.52%). DGX annual EBITDA is now -45.52% below its all-time high of $3.16 billion, reached on 31 December 2021.DGX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$470.00 M
-$8.00 M-1.67%
30 September 2024
Summary:
Quest Diagnostics Incorporated quarterly earnings before interest, taxes, depreciation & amortization is currently $470.00 million, with the most recent change of -$8.00 million (-1.67%) on 30 September 2024. Over the past year, it has increased by +$78.00 million (+19.90%). DGX quarterly EBITDA is now -50.79% below its all-time high of $955.00 million, reached on 30 June 2021.DGX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$1.77 B
+$19.00 M+1.08%
30 September 2024
Summary:
Quest Diagnostics Incorporated TTM earnings before interest, taxes, depreciation & amortization is currently $1.77 billion, with the most recent change of +$19.00 million (+1.08%) on 30 September 2024. Over the past year, it has increased by +$39.00 million (+2.25%). DGX TTM EBITDA is now -49.40% below its all-time high of $3.50 billion, reached on 30 June 2021.DGX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +19.9% | +2.3% |
| 3 y3 years | -45.5% | -27.2% | -43.9% |
| 5 y5 years | +8.6% | +3.5% | +11.8% |
DGX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -45.5% | at low | -40.7% | +80.1% | -48.0% | +10.6% |
| 5 y | 5 years | -45.5% | +22.6% | -50.8% | +91.8% | -49.4% | +24.6% |
| alltime | all time | -45.5% | +442.7% | -50.8% | +1596.8% | -49.4% | +4512.0% |
Quest Diagnostics Incorporated EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $470.00 M(-1.7%) | $1.77 B(+1.1%) |
| June 2024 | - | $478.00 M(+10.9%) | $1.75 B(+0.6%) |
| Mar 2024 | - | $431.00 M(+9.9%) | $1.74 B(+0.6%) |
| Dec 2023 | $1.72 B(-5.4%) | $392.00 M(-13.1%) | $1.73 B(+8.2%) |
| Sept 2023 | - | $451.00 M(-3.6%) | $1.60 B(-2.7%) |
| June 2023 | - | $468.00 M(+11.2%) | $1.65 B(0.0%) |
| Mar 2023 | - | $421.00 M(+61.3%) | $1.65 B(-9.6%) |
| Dec 2022 | $1.82 B(-42.4%) | $261.00 M(-47.4%) | $1.82 B(-17.5%) |
| Sept 2022 | - | $496.00 M(+6.0%) | $2.21 B(-11.9%) |
| June 2022 | - | $468.00 M(-21.3%) | $2.50 B(-16.3%) |
| Mar 2022 | - | $595.00 M(-7.9%) | $2.99 B(-5.4%) |
| Dec 2021 | $3.16 B(+31.0%) | $646.00 M(-18.5%) | $3.16 B(-7.3%) |
| Sept 2021 | - | $793.00 M(-17.0%) | $3.41 B(-2.6%) |
| June 2021 | - | $955.00 M(+24.8%) | $3.50 B(+19.4%) |
| Mar 2021 | - | $765.00 M(-14.6%) | $2.93 B(+21.6%) |
| Dec 2020 | $2.41 B(+52.1%) | $896.00 M(+1.4%) | $2.41 B(+22.4%) |
| Sept 2020 | - | $884.00 M(+129.0%) | $1.97 B(+32.9%) |
| June 2020 | - | $386.00 M(+57.6%) | $1.48 B(-0.4%) |
| Mar 2020 | - | $245.00 M(-46.0%) | $1.49 B(-6.1%) |
| Dec 2019 | $1.58 B(+12.9%) | $454.00 M(+14.4%) | $1.58 B(+11.5%) |
| Sept 2019 | - | $397.00 M(+1.3%) | $1.42 B(+0.9%) |
| June 2019 | - | $392.00 M(+15.0%) | $1.41 B(+0.6%) |
| Mar 2019 | - | $341.00 M(+17.2%) | $1.40 B(-0.2%) |
| Dec 2018 | $1.40 B(-3.4%) | $291.00 M(-24.4%) | $1.40 B(-3.8%) |
| Sept 2018 | - | $385.00 M(+0.3%) | $1.46 B(+1.3%) |
| June 2018 | - | $384.00 M(+11.6%) | $1.44 B(-0.8%) |
| Mar 2018 | - | $344.00 M(-0.6%) | $1.45 B(-0.1%) |
| Dec 2017 | $1.45 B(-1.8%) | $346.00 M(-5.5%) | $1.45 B(+0.3%) |
| Sept 2017 | - | $366.00 M(-7.6%) | $1.45 B(-1.6%) |
| June 2017 | - | $396.00 M(+14.8%) | $1.47 B(-5.3%) |
| Mar 2017 | - | $345.00 M(+1.2%) | $1.55 B(+5.1%) |
| Dec 2016 | $1.48 B(-5.3%) | $341.00 M(-12.3%) | $1.48 B(+1.7%) |
| Sept 2016 | - | $389.00 M(-18.8%) | $1.45 B(-17.8%) |
| June 2016 | - | $479.00 M(+77.4%) | $1.77 B(+10.4%) |
| Mar 2016 | - | $270.00 M(-14.6%) | $1.60 B(+2.7%) |
| Dec 2015 | $1.56 B(+19.7%) | $316.00 M(-55.1%) | $1.56 B(-1.4%) |
| Sept 2015 | - | $704.00 M(+125.6%) | $1.58 B(+30.4%) |
| June 2015 | - | $312.00 M(+36.8%) | $1.21 B(-3.2%) |
| Mar 2015 | - | $228.00 M(-32.5%) | $1.25 B(-4.8%) |
| Dec 2014 | $1.30 B(-26.3%) | $338.00 M(+0.9%) | $1.32 B(+0.9%) |
| Sept 2014 | - | $335.00 M(-4.8%) | $1.30 B(-24.9%) |
| June 2014 | - | $352.00 M(+21.0%) | $1.74 B(-0.9%) |
| Mar 2014 | - | $291.00 M(-10.7%) | $1.75 B(-1.0%) |
| Dec 2013 | $1.77 B(+16.2%) | $326.00 M(-57.5%) | $1.77 B(-1.0%) |
| Sept 2013 | - | $767.00 M(+108.4%) | $1.79 B(+27.3%) |
| June 2013 | - | $368.00 M(+19.5%) | $1.40 B(-3.0%) |
| Mar 2013 | - | $308.00 M(-10.6%) | $1.45 B(-4.9%) |
| Dec 2012 | $1.52 B(+17.0%) | $344.34 M(-10.3%) | $1.52 B(-3.5%) |
| Sept 2012 | - | $383.70 M(-6.9%) | $1.58 B(-1.1%) |
| June 2012 | - | $411.94 M(+7.6%) | $1.59 B(+0.9%) |
| Mar 2012 | - | $383.02 M(-4.0%) | $1.58 B(+21.4%) |
| Dec 2011 | $1.30 B(-17.3%) | $399.00 M(-0.4%) | $1.30 B(+3.4%) |
| Sept 2011 | - | $400.68 M(+0.9%) | $1.26 B(-0.9%) |
| June 2011 | - | $397.10 M(+279.7%) | $1.27 B(-2.5%) |
| Mar 2011 | - | $104.58 M(-70.7%) | $1.30 B(-17.3%) |
| Dec 2010 | $1.57 B | $356.50 M(-13.4%) | $1.57 B(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $411.63 M(-4.1%) | $1.61 B(-0.8%) |
| June 2010 | - | $429.41 M(+14.1%) | $1.62 B(+0.3%) |
| Mar 2010 | - | $376.45 M(-3.6%) | $1.62 B(-1.0%) |
| Dec 2009 | $1.63 B(+11.0%) | $390.41 M(-8.1%) | $1.63 B(+1.6%) |
| Sept 2009 | - | $424.61 M(+0.2%) | $1.61 B(+2.7%) |
| June 2009 | - | $423.96 M(+8.1%) | $1.56 B(+2.5%) |
| Mar 2009 | - | $392.22 M(+7.5%) | $1.53 B(+3.2%) |
| Dec 2008 | $1.47 B(+10.5%) | $364.87 M(-4.8%) | $1.48 B(-1.1%) |
| Sept 2008 | - | $383.08 M(-0.5%) | $1.49 B(+0.9%) |
| June 2008 | - | $385.13 M(+11.5%) | $1.48 B(+4.1%) |
| Mar 2008 | - | $345.52 M(-9.2%) | $1.42 B(+7.1%) |
| Dec 2007 | $1.33 B(+0.3%) | $380.69 M(+2.9%) | $1.33 B(+4.1%) |
| Sept 2007 | - | $370.02 M(+13.0%) | $1.28 B(+2.2%) |
| June 2007 | - | $327.31 M(+30.3%) | $1.25 B(-1.5%) |
| Mar 2007 | - | $251.21 M(-23.5%) | $1.27 B(-4.3%) |
| Dec 2006 | $1.33 B(+12.0%) | $328.49 M(-4.0%) | $1.33 B(+1.6%) |
| Sept 2006 | - | $342.25 M(-1.3%) | $1.30 B(+3.9%) |
| June 2006 | - | $346.89 M(+12.7%) | $1.26 B(+3.5%) |
| Mar 2006 | - | $307.78 M(+0.1%) | $1.21 B(+3.0%) |
| Dec 2005 | $1.18 B(+12.8%) | $307.60 M(+4.7%) | $1.18 B(+4.9%) |
| Sept 2005 | - | $293.81 M(-3.4%) | $1.12 B(+1.8%) |
| June 2005 | - | $304.20 M(+11.7%) | $1.10 B(+2.9%) |
| Mar 2005 | - | $272.44 M(+7.9%) | $1.07 B(+2.1%) |
| Dec 2004 | $1.05 B(+10.4%) | $252.52 M(-7.9%) | $1.05 B(+1.5%) |
| Sept 2004 | - | $274.24 M(+0.5%) | $1.03 B(+1.8%) |
| June 2004 | - | $272.87 M(+9.2%) | $1.02 B(+1.6%) |
| Mar 2004 | - | $249.95 M(+5.3%) | $1.00 B(+5.2%) |
| Dec 2003 | $950.36 M(+31.3%) | $237.41 M(-7.3%) | $950.59 M(+6.4%) |
| Sept 2003 | - | $256.05 M(-0.4%) | $893.16 M(+7.7%) |
| June 2003 | - | $256.95 M(+28.4%) | $829.02 M(+8.3%) |
| Mar 2003 | - | $200.18 M(+11.2%) | $765.24 M(+5.7%) |
| Dec 2002 | $723.84 M(+29.5%) | $179.98 M(-6.2%) | $723.84 M(+5.4%) |
| Sept 2002 | - | $191.91 M(-0.7%) | $686.67 M(+7.8%) |
| June 2002 | - | $193.17 M(+21.7%) | $636.99 M(+7.2%) |
| Mar 2002 | - | $158.78 M(+11.2%) | $594.04 M(+6.2%) |
| Dec 2001 | $559.12 M(+23.7%) | $142.81 M(+0.4%) | $559.12 M(+9.9%) |
| Sept 2001 | - | $142.23 M(-5.3%) | $508.71 M(+3.6%) |
| June 2001 | - | $150.22 M(+21.3%) | $491.27 M(+3.2%) |
| Mar 2001 | - | $123.85 M(+34.0%) | $476.11 M(+5.3%) |
| Dec 2000 | $452.11 M(+86.2%) | $92.41 M(-25.9%) | $452.11 M(+1.3%) |
| Sept 2000 | - | $124.79 M(-7.6%) | $446.20 M(+14.3%) |
| June 2000 | - | $135.06 M(+35.3%) | $390.42 M(+28.6%) |
| Mar 2000 | - | $99.85 M(+15.4%) | $303.50 M(+25.0%) |
| Dec 1999 | $242.80 M(+48.9%) | $86.50 M(+25.4%) | $242.87 M(+24.6%) |
| Sept 1999 | - | $69.00 M(+43.3%) | $194.87 M(+18.4%) |
| June 1999 | - | $48.15 M(+22.8%) | $164.57 M(+2.2%) |
| Mar 1999 | - | $39.22 M(+1.9%) | $161.02 M(-1.3%) |
| Dec 1998 | $163.10 M(+7.9%) | $38.50 M(-0.5%) | $163.20 M(+7.1%) |
| Sept 1998 | - | $38.70 M(-13.2%) | $152.40 M(+0.7%) |
| June 1998 | - | $44.60 M(+7.7%) | $151.30 M(-1.7%) |
| Mar 1998 | - | $41.40 M(+49.5%) | $153.90 M(+2.0%) |
| Dec 1997 | $151.10 M(-130.1%) | $27.70 M(-26.3%) | $150.90 M(+22.5%) |
| Sept 1997 | - | $37.60 M(-20.3%) | $123.20 M(+43.9%) |
| June 1997 | - | $47.20 M(+22.9%) | $85.60 M(+122.9%) |
| Mar 1997 | - | $38.40 M | $38.40 M |
| Dec 1996 | -$502.19 M | - | - |
FAQ
- What is Quest Diagnostics Incorporated annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly EBITDA year-on-year change?
- What is Quest Diagnostics Incorporated TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated TTM EBITDA year-on-year change?
What is Quest Diagnostics Incorporated annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DGX is $1.72 B
What is the all time high annual EBITDA for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high annual earnings before interest, taxes, depreciation & amortization is $3.16 B
What is Quest Diagnostics Incorporated quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DGX is $470.00 M
What is the all time high quarterly EBITDA for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high quarterly earnings before interest, taxes, depreciation & amortization is $955.00 M
What is Quest Diagnostics Incorporated quarterly EBITDA year-on-year change?
Over the past year, DGX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$78.00 M (+19.90%)
What is Quest Diagnostics Incorporated TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DGX is $1.77 B
What is the all time high TTM EBITDA for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high TTM earnings before interest, taxes, depreciation & amortization is $3.50 B
What is Quest Diagnostics Incorporated TTM EBITDA year-on-year change?
Over the past year, DGX TTM earnings before interest, taxes, depreciation & amortization has changed by +$39.00 M (+2.25%)